Toggle navigation
Search
Tree View
MeSH on Demand
MeSH 2023
About
Suggestions
Contact Us
evinacumab
MeSH Supplementary Concept Data 2024
Details
Concepts
MeSH Supplementary
evinacumab
Unique ID
C000621590
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C000621590
Entry Term(s)
REGN-1500
REGN1500
evinacumab-dgnb
evkeeza
Registry Number
T8B2ORP1DW
Heading Mapped to
*Antibodies, Monoclonal
Frequency
38
Note
an ANGPTL3-blocking antibody; FDA approved for the treatment of homozygous familial hypercholesterolemia.
Source
N Engl J Med. 2017 Jul 20;377(3):211-221.
Date of Entry
2017/07/30
Revision Date
2024/03/15
Expand All
Collapse All
evinacumab
Preferred
Concept UI
M000634681
Registry Number
T8B2ORP1DW
Terms
evinacumab
Preferred Term
Term UI
T000929342
Date
07/30/2017
LexicalTag
NON
ThesaurusID
NLM (2017)
evinacumab-dgnb
Narrower
Concept UI
M000767487
Terms
evinacumab-dgnb
Preferred Term
Term UI
T001108757
Date
07/14/2021
LexicalTag
NON
ThesaurusID
NLM (2021)
evkeeza
Narrower
Concept UI
M000750389
Terms
evkeeza
Preferred Term
Term UI
T001108756
Date
07/14/2021
LexicalTag
TRD
ThesaurusID
NLM (2021)
REGN-1500
Broader
Concept UI
M000654457
Terms
REGN-1500
Preferred Term
Term UI
T000965935
Date
08/20/2019
LexicalTag
LAB
ThesaurusID
NLM (2020)
REGN1500
Term UI
T000965936
Date
08/20/2019
LexicalTag
LAB
ThesaurusID
NLM (2020)
page delivered in 0.004s